Remde Y - Search Results

1

Procedures for the GMP-Compliant Production and Quality Control of [¹⁸F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer.

Cardinale J, Martin R, Remde Y, Schäfer M, Hienzsch A, Hübner S, Zerges AM, Marx H, Hesse R, Weber K, Smits R, Hoepping A, Müller M, Neels OC, Kopka K. Cardinale J, et al. Among authors: remde y. Pharmaceuticals (Basel). 2017 Sep 27;10(4):77. doi: 10.3390/ph10040077. Pharmaceuticals (Basel). 2017. PMID: 28953234 Free PMC article.

2

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer.

Eder M, Neels O, Müller M, Bauder-Wüst U, Remde Y, Schäfer M, Hennrich U, Eisenhut M, Afshar-Oromieh A, Haberkorn U, Kopka K. Eder M, et al. Among authors: remde y. Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96. doi: 10.3390/ph7070779. Pharmaceuticals (Basel). 2014. PMID: 24983957 Free PMC article.

3

Designing tracers for PET imaging of the urokinase-type plasminogen activator receptor from a cyclic uPA-derived peptide: first in vitro evaluations.

Wacker A, Bauder-Wüst U, Schäfer M, Schmidt J, Remde Y, Stadlbauer S, Eder M, Liolios C, Kopka K. Wacker A, et al. Among authors: remde y. J Labelled Comp Radiopharm. 2019 Jun 30;62(8):483-494. doi: 10.1002/jlcr.3735. Epub 2019 Jun 6. J Labelled Comp Radiopharm. 2019. PMID: 30970388

4

HBED-NN: A Bifunctional Chelator for Constructing Radiopharmaceuticals.

Makarem A, Klika KD, Litau G, Remde Y, Kopka K. Makarem A, et al. Among authors: remde y. J Org Chem. 2019 Jun 7;84(11):7501-7508. doi: 10.1021/acs.joc.9b00832. Epub 2019 May 15. J Org Chem. 2019. PMID: 31064181

5

Development of PSMA-1007-Related Series of ¹⁸F-Labeled Glu-Ureido-Type PSMA Inhibitors.

Cardinale J, Roscher M, Schäfer M, Geerlings M, Benešová M, Bauder-Wüst U, Remde Y, Eder M, Nováková Z, Motlová L, Barinka C, Giesel FL, Kopka K. Cardinale J, et al. Among authors: remde y. J Med Chem. 2020 Oct 8;63(19):10897-10907. doi: 10.1021/acs.jmedchem.9b01479. Epub 2020 Sep 22. J Med Chem. 2020. PMID: 32852205

6

Synthesis of tritium-labeled Lu-PSMA-617: Alternative tool for biological evaluation of radiometal-based pharmaceuticals.

Bauder-Wüst U, Schäfer M, Winter R, Remde Y, Roscher M, Breyl H, Poethko T, Tömböly C, Benešová-Schäfer M. Bauder-Wüst U, et al. Among authors: remde y. Appl Radiat Isot. 2023 Jul;197:110819. doi: 10.1016/j.apradiso.2023.110819. Epub 2023 Apr 11. Appl Radiat Isot. 2023. PMID: 37119703

7

Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?

Taş H, Bakos G, Bauder-Wüst U, Schäfer M, Remde Y, Roscher M, Benešová-Schäfer M. Taş H, et al. Among authors: remde y. Pharmaceuticals (Basel). 2024 Apr 16;17(4):513. doi: 10.3390/ph17040513. Pharmaceuticals (Basel). 2024. PMID: 38675472 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7 results

Search Page